INTRODUCTION
Aplastic anemia (AA) is a potentially severe bone marrow (BM) disorder characterized by peripheral pancytopenia and BM that is largely devoid of hematopoietic cells and is replaced by fatty tissue, while retaining the basic marrow architecture or stroma (1) . The treatment of choice for severe AA (SAA) in patients under the age of 40 yr is bone marrow transplantation (BMT), whereas patients with moderate AA, patients with SAA who lack a compatible donor, and those over the age of 40 yr are treated with immunosuppressive agents (1, 2) .
Magnetic resonance (MR) imaging is a noninvasive and relatively rapid method of BM study because of its exclusive ability to directly show a large volume of BM (3) (4) (5) . MR imaging of BM in AA has been widely reported, but prognostic implication of MR imaging according to the treatment methods used has been only reported in a few series (6) (7) (8) (9) . The aim of this study was to investigate the features of MR imaging of BM for monitoring the therapeutic effects of BMT or immunosuppressive therapy in patients with SAA.
MATERIALS AND METHODS
MR imaging of BM was retrospectively reviewed in 16 patients (13 males and 3 females) who had attained complete clinical responses following allogeneic BMT or immunosuppressive therapy with antilymphocyte globulin (ALG) and cyclosporine A. Response was defined as reaching complete independence of transfusions. The mean age of the patients was 26 (range, 15-38) yr. Eight patients were treated with BMT and the others with ALG and cyclosporine A. The interval between MR examination of BM and treatment was about 33 (21 in BMT group and 59 in ALG group) weeks. In two of eight patients with BMT and six of eight patients with immunosuppressive therapy, MR imaging of BM was performed prior to treatment.
MR imaging of BM was performed with a 0.5T (Gyroscan T5, Phillips, Eindhoven, Netherlands) or a 1.5T (Magnetom plus, Siemens, Erlangen, Germany) superconductive MR unit. Sagittal T1-weighted images (T1WI, TR/TE=560/30 msec at 0.5T or 500/12 msec at 1.5T) and short tau inversion recovery (STIR, TR/TE/TI=1,400/30/120 msec at 0.5T or 3,600/30/150 msec at 1.5T) images of the lumbar spine were obtained. Image factors were 5-mm slice thickness with
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To compare magnetic resonance (MR) images of the bone marrow (BM) after bone marrow transplantation or immunosuppressive therapy in patients with aplastic anemia (AA), MR imaging of BM was reviewed retrospectively in 16 patients (13 males and 3 females, mean age 26 yr) with AA who completely responded clinically after transplantation or immunosuppressive therapy. The signal intensity (SI) of BM was classified into four patterns according to the increasing amount of cellular marrow, i.e., pattern I to IV. SI of MR imaging of BM exhibited an increase of cellular marrows following both transplantation and immunosuppressive therapy. Of the eight patients on transplantation, the SI of the lumbar spinal BM was pattern III in two patients and IV in six on T1-weighted and short tau inversion recovery (STIR) images. In the eight patients with immunosuppressive therapy, the SI of the lumbar spinal BM was pattern II in one, III in five, and IV in two on T1-weighted images and pattern II in one, III in four, and IV in three on STIR images. SI on MR imaging of the lumbar spinal BM showed a more cellular pattern in patients on transplantation than in those on immunosuppressive therapy. a 0.5-mm intersection gap, 205×256 matrix, four signal acquisitions, and 350-mm field of view on all pulse sequences. Coronal T1WI of the pelvis (TR/TE=560/30 msec at 0.5T or 750/12 msec at 1.5T) with 6-mm slice thickness and 0.6-mm intersection gap were also obtained.
MR images were interpreted by two radiologists who reached a consensus. The signal intensity (SI) of BM from the first to fifth lumbar bodies and the pelvic bone on both T1WI and STIR images was summated visually and classified into four types according to the increasing amount of cellular marrow. On T1WI, diffusely homogeneous, high SI was classified as pattern I, hyperintense background with less than 25% of low SI nodules as pattern II, extensive mixed high and low SI with a half or more area of high SI as pattern III, and diffuse low SI with scattered high SI nodules of less than 25% as pattern IV. On STIR with reversed SI, pattern I was defined as diffusely homogeneous low SI, pattern II hypointense background with less than 25% of high SI nodules, pattern III mixed patchy high and low SI with a half or less area of high SI, and pattern IV diffusely high SI with less than 25% of low SI area.
According to SI patterns seen on T1WI and STIR images, BM was categorized as follows: I, homogeneous fatty pattern; II, focal cellular pattern; III, mixed fatty and cellular pattern; and IV, cellular pattern with focal fatty nodules. On T1WI, low signal was equal to or less than the signal of paravertebral muscle, and high signal was equal to the signal of subcutaneous fat. On STIR images with fat suppression, marrow SI was rated as high or low in relation to the signal of paravertebral muscle.
These SI patterns of MR imaging of lumbar spinal & pelvic BM were analyzed in patients with SAA following BMT or immunosuppressive therapy.
RESULTS
The clinical features and SI patterns of MR imaging of BM in 16 patients with SAA after BMT or immunosuppressive therapy are summarized in Table 1 .
In eight patients who underwent MR imaging of BM before BMT or immunosuppressive therapy, SI pattern of spinal BM changed to represent higher cellularities (from patterns I and II to patterns III and IV). Likewise, the SI pattern of the pelvic BM changed from patterns I and II to patterns II and III.
The SI patterns of MR imaging of the lumbar spinal BM after treatment were different depending on the modalities although complete responses were attained in both BMT and immunosuppressive therapy groups. Of the eight patients on BMT, SI of the lumbar spinal BM was pattern III in two patients and IV in six on TIWI and STIR images (Fig. 1) . Of the eight patients on immunosuppressive therapy, SI of lumbar vertebral BM was pattern II in one patient, III in five, and IV in two on T1WI and II in one, III in four, and IV in three patients on STIR images (Fig. 2) . The SI pattern of MR imaging of the lumbar spinal BM after BMT was more cellular, with small fatty portions, than that after immuno- suppressive therapy.
The lumbar spinal and pelvic BM after treatment showed different SI patterns: patterns III and IV were much more frequently seen in lumbar spinal BM (15 of 16 patients), whereas patterns I and II were common in pelvic BM (10 of 16 patients) on T1WI. The SI pattern on MR imaging of the pelvic BM after BMT or immunosuppressive therapy represented more fat than that of the spinal BM.
DISCUSSION
The application of MR techniques has become an important imaging modality for diagnostic and follow-up after treatment of various hematologic diseases (3) (4) (5) 10) . MR imaging is complementary to BM biopsy in that although MR shows only the gross anatomy of the marrow, it can sample a large fraction of active marrow in a single, noninvasive clinical study.
In AA, findings of MR imaging and their roles in monitoring patients have been reported (6) (7) (8) (9) (11) (12) (13) . In untreated stages, marrows demonstrate a diffuse, high SI, reflecting preponderance of fatty marrow and lack of hematopoietic marrow. After treatment, foci of low signal intensity, representing islands of hematopoietically active tissue, appear in the yellow marrow. BMT is a well-established treatment of choice for patients with SAA who have HLA-matched donors. The use of ALG alone or together with cyclosporine A is also accepted as an effective form of treatment for patients with SAA who lack HLA-matched donors and who are over 40 yr of age. In normal adults, the distribution of hematopoietic and fatty marrow relative to age has been extensively described (14) (15) (16) . Since the hematopoietic marrow remains throughout life in the lumbar spine, the pelvis, and the intertrochanteric area of the femur, these areas were assessed in our study.
The SI of MR images correlates with the density and the relaxation behavior of the protons in tissues. There are two considerable fractions of protons in normal red marrow, i.e., water and lipids. The separation and quantification of these protons within red marrow are important issues of MR imaging of BM. BMT or immunosuppressive therapy in patients with AA results in an increasing fraction of water within BM by the regeneration of hematopoietic cells (8, 9) . Our protocol included sagittal T1WI and STIR imaging of the lumbar spine and coronal T1WI of the pelvis. The short T1 relaxation time (higher SI) of the fatty marrow allows noninvasive assessment of the amount and distribution of the tissue by T1WI. STIR images characterize the yellow marrow as SI being nullified and therefore appearing black. The T1 and T2 contrast of tissues other than fat is additive, and contrast sensitivity is thus greatly enhanced (3, 17, 18) . Because the fat signal is highlighted on T1WI, whereas the cellular portion is emphasized on STIR images, one (patient No. 14) of our patients was classified as pattern III on T1WI but as IV on STIR images. Our results showed that the patients on BMT had SI of more cellular pattern than the patients on immunosuppressive therapy, despite the complete responses in both groups. However, two (No.10 and 15) of the eight patients on immunosuppressive therapy recurred with pancytopenia 1 yr later. None of the eight patients on BMT experienced a relapse of the disease during the mean three (one to six) years of average period of follow-up.
It is not well known where the initial BM recovery takes place following BMT or immunosuppressive therapy. Our results showed that SI on MR imaging of the lumbar spinal BM after therapy appeared to have a more cellular pattern than that of the pelvic BM, suggesting the earlier hematopoietic recovery in the lumbar spinal marrow cavity.
There were several limitations in our study. Firstly, initial MR imaging was available in only two cases on BMT and six on ALG therapy. Therefore, changing patterns of SI on MR imaging with the treatment could not be clearly evaluated in all patients. Secondly, the SI pattern of BM was evaluated visually, not quantitated. Lastly, all the patients studied were complete responders and patients in whom BMT or immunosuppressive therapy had failed or just induced partial responses were not included, suggesting a selection bias.
In conclusion, MR imaging of BM showed slight differences in its SI patterns, depending on the treatment modalities applied. The lumbar spinal BM showed a more cellular pattern in patients treated with BMT than in those treated with immunosuppressive agents. Recovery of BM cellularity in the lumbar spinal BM preceded that of the pelvic BM. 
